Post TAVR Cognitive Function at Short Term: Better or Worse?

Post TAVR Cognitive Function at Short TermThere is little information on the short and mid-term evolution of cognitive function after transcatheter aortic valve replacement (TAVR).

 

The aim of this study was to describe global changes in cognitive function and changes in specific cognitive domains one year after TAVR.

 

Fifty one patients undergoing TAVR, median age 80, were prospectively followed to assess cognitive function using the Montreal Cognitive Assessment Test (MoCA) at baseline, 30 days and one year. Specific cognitive functions (e.g. verbal fluency) were assessed with pertinent tests.

 

Baseline MoCA outcomes, which assesses cognition globally, was 22.71 ± 3.84. Twenty patients (39.2%) showed cognitive decline at baseline, according to test results (<23 of 30 points).

 

MoCA scores improved at short term after TAVR and remained stable at one year (p = 0.022). There were no significant changes over time in specific cognitive domain test outcomes.

 

Conclusion

TAVR improves cognitive function, which is more obvious in patients presenting cognitive decline at baseline. There was also early decline of some specific functions in one quarter of patients that persisted at one year in 10% of these patients.

 

Original Title: Serial Changes in Cognitive Function Following Transcatheter Aortic Valve Replacement.

Reference: Vincent Auffret et al. J Am Coll Cardiol. 2016;68(20):2129-2141.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...